Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Innokas Medical to produce Elekta magnetoencephalography system

Elekta : 08 May, 2007  (New Product)
Elekta Neuromag and Innokas Medical have signed an agreement that outsources production of the Elekta Neuromag magnetoencephalography (MEG) system.
The Elekta Neuromag MEG system is used for non-invasive real-time measurements of brain activity at leading research institutions and hospitals around the world.

The production, including the employees involved, will be transferred to Innokas Medical during 2007.

Elekta is reinforcing its operations in the MEG business area due to the changing market situations and the increased need for Elekta's MEG technology.

By outsourcing its MEG production to Innokas Medical, Elekta will get the benefit of a flexible and expert medical equipment production partner, while keeping the overall technical responsibility of the MEG system towards the customer.
Elekta will continue to invest in innovation and fulfilling the customers' needs in the MEG area.

For Innokas Medical, this agreement is an important step in its growth strategy.
It will strengthen the company's position as a leading medical equipment contract manufacturer in Finland.

'Non-invasive, real-time brain mapping and monitoring is considered as one of the most exciting developments in neuroscience today and the list of new applications for MEG is steadily growing and the number of installations are increasing', said Tomas Puusepp, president and CEO of Elekta.

'Elekta is the only MEG vendor on the market with the financial stability needed to be committed to the long term development of MEG technology and our production outsourcing agreement with Innokas Medical further strengthen our ability to serve neuroscience centres around the world with leading MEG technology'.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo